Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1683

HYDROCORTISONE BUTYRATE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

Basic Information

ChEMBL ID CHEMBL1683
Name HYDROCORTISONE BUTYRATE
Phase Approved
Structure Type MOL
InChI Key BMCQMVFGOVHVNG-TUFAYURCSA-N
Therapeutic ✓ Yes

Known Names

Cortisol 17-butyrate Hydrocortisone 17-butyrate Hydrocortisone butyrate Hydrocortisone-17-butyrate Locoid Locoid c Locoid crelo Locoid lipocream NSC-758433
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
20
Publications
9
Known Names
4
Indications
1
Mechanisms

Molecular Properties

432.6
MW (Da)
3.13
ALogP
6
HBA
2
HBD
100.9
PSA (Ų)
0.65
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1982
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Topical

Flags

Natural Product
USAN Stem -cort-
USAN Year 1980

Extended Properties

Molecular Formula C25H36O6
MW 432.56
Aromatic Rings 0
Heavy Atoms 31
NP-Likeness 2.14

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Glucocorticoid receptor agonist AGONIST Glucocorticoid receptor

Indications

Dermatitis, Atopic Dermatitis, Seborrheic Skin Diseases Psoriasis

ATC Classification

D07AB02
hydrocortisone butyrate
Level 1: DERMATOLOGICALS
Level 2: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS

Activity Summary

EC50 2 meas. best 8.71

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
EC50 8.71 8.71 2.0 1
Mineralocorticoid receptor
CHEMBL1994
EC50 8.53 8.53 2.9 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 2
- 10.1101/2020.04.21.054387 SARS-CoV-2 1
23571415 10.1124/mol.112.084152 Solute carrier organic anion transporter family member 1B3 1
23571415 10.1124/mol.112.084152 Solute carrier organic anion transporter family member 1B1 1
37468498 10.1038/s41467-023-40064-9 Voltage-gated inwardly rectifying potassium channel KCNH2 1
37468498 10.1038/s41467-023-40064-9 Voltage-dependent L-type calcium channel subunit alpha-1C 1
37468498 10.1038/s41467-023-40064-9 Glutamate receptor ionotropic, NMDA 1 1
37468498 10.1038/s41467-023-40064-9 Beta-1 adrenergic receptor 1
19056282 10.1016/j.bmc.2008.11.040 ADMET 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent dopamine transporter 1
37468498 10.1038/s41467-023-40064-9 Neuronal acetylcholine receptor subunit alpha-4 1
3783574 10.1021/jm00161a001 Homo sapiens 1
7097729 10.1021/jm00348a027 Glucocorticoid receptor 1

Data from ChEMBL 36 via Core Engine